Literature DB >> 23627375

Disrupted Cl(-) homeostasis contributes to reductions in the inhibitory efficacy of diazepam during hyperexcited states.

Tarek Z Deeb1, Yasuko Nakamura, Greg D Frost, Paul A Davies, Stephen J Moss.   

Abstract

The K(+) -Cl(-) cotransporter type 2 is the major Cl(-) extrusion mechanism in most adult neurons. This process in turn leads to Cl(-) influx upon activation of γ-aminobutyric acid type A (GABAA ) receptors and the canonical hyperpolarising inhibitory postsynaptic potential. Several neurological disorders are treated with drugs that target and enhance GABAA receptor signaling, including the commonly used benzodiazepine diazepam and the anesthetic propofol. Some of these disorders are also associated with deficits in GABAA signaling and become less sensitive to therapeutic drugs that target GABAA receptors. To date, it is unknown if alterations in the neuronal Cl(-) gradient affect the efficacies of diazepam and propofol. We therefore used the in vitro model of glutamate-induced hyperexcitability to test if alterations in the Cl(-) gradient affect the efficacy of GABAA modulators. We exclusively utilised the gramicidin perforated-patch-clamp configuration to preserve the endogenous Cl(-) gradient in rat neurons. Brief exposure to glutamate reduced the inhibitory efficacy of diazepam within 5 min, which was caused by the collapse of the Cl(-) gradient, and not due to reductions in GABAA receptor number. Unlike diazepam, propofol retained its efficacy by shunting the membrane conductance despite the glutamate-induced appearance of depolarising GABAA -mediated currents. Similarly, pharmacological inhibition of K(+) -Cl(-) cotransporter type 2 by furosemide disrupted Cl(-) homeostasis and reduced the efficacy of diazepam but not propofol. Collectively our results suggest that pathological hyperexcitable conditions could cause the rapid accumulation of intracellular Cl(-) and the appearance of depolarising GABAA -mediated currents that would decrease the efficacy of diazepam.
© 2013 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  K+-Cl− cotransporter type 2; glutamate; neurons; propofol; rat

Mesh:

Substances:

Year:  2013        PMID: 23627375      PMCID: PMC3735799          DOI: 10.1111/ejn.12241

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  69 in total

1.  Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus.

Authors:  David E Naylor; Hantao Liu; Claude G Wasterlain
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

Review 2.  Status epilepticus: evidence and controversy.

Authors:  Juan José García Peñas; Albert Molins; Javier Salas Puig
Journal:  Neurologist       Date:  2007-11       Impact factor: 1.398

3.  Relationship between neuronal vulnerability and potassium-chloride cotransporter 2 immunoreactivity in hippocampus following transient forebrain ischemia.

Authors:  E Papp; C Rivera; K Kaila; T F Freund
Journal:  Neuroscience       Date:  2008-04-07       Impact factor: 3.590

4.  Effects of drugs on the initiation and maintenance of status epilepticus induced by administration of pilocarpine to lithium-pretreated rats.

Authors:  R A Morrisett; R S Jope; O C Snead
Journal:  Exp Neurol       Date:  1987-07       Impact factor: 5.330

5.  Glutamate-induced elevations in intracellular chloride concentration in hippocampal cell cultures derived from EYFP-expressing mice.

Authors:  Jennifer E Slemmer; Shinichi Matsushita; Chris I De Zeeuw; John T Weber; Thomas Knöpfel
Journal:  Eur J Neurosci       Date:  2004-06       Impact factor: 3.386

Review 6.  The extracellular space and epileptic activity in the adult brain: explaining the antiepileptic effects of furosemide and bumetanide.

Authors:  Daryl W Hochman
Journal:  Epilepsia       Date:  2012-06       Impact factor: 5.864

7.  Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke.

Authors:  Andrew N Clarkson; Ben S Huang; Sarah E Macisaac; Istvan Mody; S Thomas Carmichael
Journal:  Nature       Date:  2010-11-03       Impact factor: 49.962

8.  The reciprocal regulation of stress hormones and GABA(A) receptors.

Authors:  Istvan Mody; Jamie Maguire
Journal:  Front Cell Neurosci       Date:  2012-01-30       Impact factor: 5.505

9.  NMDA receptor activity downregulates KCC2 resulting in depolarizing GABAA receptor-mediated currents.

Authors:  Henry H C Lee; Tarek Z Deeb; Joshua A Walker; Paul A Davies; Stephen J Moss
Journal:  Nat Neurosci       Date:  2011-05-01       Impact factor: 24.884

10.  Deficits in phosphorylation of GABA(A) receptors by intimately associated protein kinase C activity underlie compromised synaptic inhibition during status epilepticus.

Authors:  Miho Terunuma; Jianwei Xu; Mansi Vithlani; Werner Sieghart; Josef Kittler; Menelas Pangalos; Philip G Haydon; Douglas A Coulter; Stephen J Moss
Journal:  J Neurosci       Date:  2008-01-09       Impact factor: 6.167

View more
  18 in total

1.  Developmentally regulated KCC2 phosphorylation is essential for dynamic GABA-mediated inhibition and survival.

Authors:  Miho Watanabe; Jinwei Zhang; M Shahid Mansuri; Jingjing Duan; Jason K Karimy; Eric Delpire; Seth L Alper; Richard P Lifton; Atsuo Fukuda; Kristopher T Kahle
Journal:  Sci Signal       Date:  2019-10-15       Impact factor: 8.192

2.  Excitatory GABAergic signalling is associated with benzodiazepine resistance in status epilepticus.

Authors:  Richard J Burman; Joshua S Selfe; John Hamin Lee; Maurits van den Berg; Alexandru Calin; Neela K Codadu; Rebecca Wright; Sarah E Newey; R Ryley Parrish; Arieh A Katz; Jo M Wilmshurst; Colin J Akerman; Andrew J Trevelyan; Joseph V Raimondo
Journal:  Brain       Date:  2019-11-01       Impact factor: 13.501

3.  Bumetanide reduces seizure progression and the development of pharmacoresistant status epilepticus.

Authors:  Sudhir Sivakumaran; Jamie Maguire
Journal:  Epilepsia       Date:  2015-12-11       Impact factor: 5.864

4.  KCC2 activity is critical in limiting the onset and severity of status epilepticus.

Authors:  Liliya Silayeva; Tarek Z Deeb; Rochelle M Hines; Matt R Kelley; Michaelanne B Munoz; Henry H C Lee; Nicholas J Brandon; John Dunlop; Jaime Maguire; Paul A Davies; Stephen J Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-02       Impact factor: 11.205

5.  Mannitol decreases neocortical epileptiform activity during early brain development via cotransport of chloride and water.

Authors:  J Glykys; E Duquette; N Rahmati; K Duquette; K J Staley
Journal:  Neurobiol Dis       Date:  2019-02-01       Impact factor: 5.996

6.  Genetically encoded impairment of neuronal KCC2 cotransporter function in human idiopathic generalized epilepsy.

Authors:  Kristopher T Kahle; Nancy D Merner; Perrine Friedel; Liliya Silayeva; Bo Liang; Arjun Khanna; Yuze Shang; Pamela Lachance-Touchette; Cynthia Bourassa; Annie Levert; Patrick A Dion; Brian Walcott; Dan Spiegelman; Alexandre Dionne-Laporte; Alan Hodgkinson; Philip Awadalla; Hamid Nikbakht; Jacek Majewski; Patrick Cossette; Tarek Z Deeb; Stephen J Moss; Igor Medina; Guy A Rouleau
Journal:  EMBO Rep       Date:  2014-06-13       Impact factor: 8.807

7.  Combinatorial Targeting of Distributed Forebrain Networks Reverses Noise Hypersensitivity in a Model of Autism Spectrum Disorder.

Authors:  Miho Nakajima; L Ian Schmitt; Guoping Feng; Michael M Halassa
Journal:  Neuron       Date:  2019-10-21       Impact factor: 17.173

Review 8.  K-Cl cotransporter KCC2--a moonlighting protein in excitatory and inhibitory synapse development and function.

Authors:  Peter Blaesse; Tobias Schmidt
Journal:  Pflugers Arch       Date:  2014-06-10       Impact factor: 3.657

9.  Chronic stress shifts the GABA reversal potential in the hippocampus and increases seizure susceptibility.

Authors:  Georgina MacKenzie; Jamie Maguire
Journal:  Epilepsy Res       Date:  2014-10-23       Impact factor: 3.045

10.  The small molecule CLP257 does not modify activity of the K+-Cl- co-transporter KCC2 but does potentiate GABAA receptor activity.

Authors:  Ross A Cardarelli; Karen Jones; Lucie I Pisella; Heike J Wobst; Lisa J McWilliams; Paul M Sharpe; Matthew P Burnham; David J Baker; Ilona Chudotvorova; Justine Guyot; Liliya Silayeva; Danielle H Morrow; Niek Dekker; Stephen Zicha; Paul A Davies; Jörg Holenz; Mark E Duggan; John Dunlop; Robert J Mather; Qi Wang; Igor Medina; Nicholas J Brandon; Tarek Z Deeb; Stephen J Moss
Journal:  Nat Med       Date:  2017-12-07       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.